Ephraim F. Gildor

Argos Capital Management LLC provides financial advisory services. Its services include interim funding, planning and advisory services. The company is headquartered in New York, NY.

Sequenta, Inc. operates as a biotech company which discovers and develops clinical diagnostics based on immune system status. It develops molecular diagnostic assays based on a sequencing approach to the profiling of T and B cell receptor repertoires. The firm also provides sequencing-based test for minimal residual disease for leukemia and lymphoma. The company was founded by Thomas D. Willis and Malek Faham in 2007 and is headquartered in South San Francisco, CA.

Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA.

Axiom Investment Advisors LLC provides foreign currency trading services. The private company is based in Houston, TX. The company was founded by Ephraim F. Gildor.

Founded in 1995, Knight Equity Markets LP is a broker/dealer located in Jersey City, New Jersey. The firm is a subsidiary of Knight Capital Group, Inc. (NYSE Euronext: KCG), a leading market maker providing liquidity both on- and off-exchange in US and European equities, options and foreign exchange. Knight Equity Markets provides a full array of trading and execution services for their clients. They do not provide any internal research

Part of Virtu Financial, Inc., Arbitrade Holdings LLC is a company that markets options on individual equities, equity indices, fixed income instruments, and certain commodities. The company is based in Minnetonka, MN. The company was founded by Ephraim F. Gildor. Arbitrade Holdings was acquired by Knight Capital Group, Inc. on January 12, 2000 for $439.24 million.